What is the mechanism of action of talquetamab-tgvs?

Talquetamab(talquetamab-tgvs) is a bispecific T cell-binding antibody that binds to T expressed on the surface of CD3 Receptors and protein-coupled receptors expressed on the surface of multiple myeloma cells and non-malignant plasma cells, as well as epithelial cells in healthy tissues such as skin and keratinized tissues of the tongue. (GPRC5D). In vitro, taktarumab-activated T cells induced the release of pro-inflammatory cytokines and led to lysis of multiple myeloma cells. Taktarumabhas anti-tumor activity in mouse models of multiple myeloma. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.